Steven Cohen’s Contineum Therapeutics CTNM Stock Holding History
Bought
Maintained
Sold
Other funds holding CTNM
Steven Cohen's CTNM Position: Q3 2026 in Review
Steven Cohen reduced its Contineum Therapeutics (CTNM) stake by 8.6% in Q3 2026, selling an estimated $33.2K and leaving 23,550 shares worth $316K. The position accounts for ﹤0.01% of the portfolio, ranked #3326.
Steven Cohen first reported a position in CTNM in Q2 2025 and has held it in 6 quarters since. The position peaked at $8.68M in Q4 2025. 118 funds tracked by Wall St. Rank hold CTNM as of Q3 2026.
- Steven Cohen held 23,550 shares of Contineum Therapeutics worth $316K as of Q3 2026.
- Steven Cohen sold 2,229 Contineum Therapeutics shares in Q3 2026, an estimated $33.2K.
- Contineum Therapeutics made up ﹤0.01% of Steven Cohen's portfolio in Q3 2026, its #3326 holding.
- Steven Cohen first reported a position in Contineum Therapeutics in Q2 2025 and has held it in 6 quarters since.
- Steven Cohen's Contineum Therapeutics position peaked at $8.68M in Q4 2025.
- 118 funds tracked by Wall St. Rank held Contineum Therapeutics as of Q3 2026.
Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.